Laurion Capital Management LP Surrozen, Inc. Transaction History

Laurion Capital Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.14 - $3.43 $780,036 - $1.25 Million	-364,503 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$2.2 - $6.01 $342,093 - $934,536	-155,497 Reduced 29.9%	364,503 $1.1 Million
Q4 2021 Feb 14, 2022	BUY	$6.0 - $9.92 $900,000 - $1.49 Million	150,000 Added 40.54%	520,000 $3.35 Million
Q3 2021 Nov 15, 2021	BUY	$6.98 - $12.03 $2.58 Million - $4.45 Million	370,000 New	370,000 $2.62 Million

4.52M

Ticker SRZN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,122,900
Market Cap $342M
Description
Surrozen, Inc., a biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair and regeneration. It is developing tissue-specific antibodies with application across various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, a...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.